VEGFA and glioblastoma: Patients with GBM usually have abnormalities in platelet-derived growth factor receptor (PDGFRA) and mutations in the vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) in addition to EGFR dysregulation [70].